Leukoencephalopathies Associated with Disorders of Cobalamin and Folate Metabolism

Abstract

Disorders of cobalamin and folate intracellular metabolism that result in defective remethylation of homocysteine to methionine are associated with leukodystrophy, whereas disorders of cobalamin transport generally are not. Cobalamin derivatives are needed for only two reactions in man; remethylation of homocysteine to methionine, with methylcobalamin as a cofactor for methionine synthase, and the conversion of methylmalonyl-coenzyme A to succinyl coenzyme A by methylmalonyl-CoA mutase, with adenosylcobalamin as a cofactor. Mutations at various metabolic steps affect the synthesis of adenosylcobalamin (CblA, CblB, and CblD2), methylcobalamin (CblE, CblG, and CblD1), or both of these (CblF, CblD, and CblC). The most common disorder of folate metabolism, 5,10-methylenetetrahydrofolate deficiency, also affects remethylation and presents with leukodystrophy. Pathways of cobalamin and folate metabolism intersect at one site, methionine synthase. Patients with the remethylating disorders present acutely or chronically with significant neurologic, hematologic, vascular, and other symptoms. Circulating levels of cobalamin and folate are usually normal in these disorders, and initial diagnosis is aided by measurement of homocysteine and methylmalonic acid in blood or urine, together with hematologic tests. Current diagnosis is often by newborn screening. These disorders all show autosomal recessive inheritance, and all are treatable, although with variable outcome.

Keywords

cobalamin - folic acid - leukoencephalopathy - CblC - homocysteine

• References

• 1 Hörster F, Surtees R, Hoffmann GF. Disorders of intermediary metabolism: toxic leukoencephalopathies. J Inherit Metab Dis 2005; 28 (3) 345-356
• 2 Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet 2011; 157 (1) 33-44
• 3 Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Hematol 2006; 134 (2) 125-136
• 4 Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr 2011; 94 (2) 666S-672S
• 5 Schiff M, Ogier de Baulny H, Bard G , et al. Should transcobalamin deficiency be treated aggressively?. J Inherit Metab Dis 2010; 33 (3) 223-229
• 6 Lerner-Ellis JP, Tirone JC, Pawelek PD , et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 2006; 38 (1) 93-100
• 7 Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis 2012; 35 (1) 103-114
• 8 Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 2012; 35 (1) 91-102
• 9 Profitlich LE, Kirmse B, Wasserstein MP, Diaz GA, Srivastava S. High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. Mol Genet Metab 2009; 98 (4) 344-348
• 10 Longo D, Fariello G, Dionisi-Vici C , et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics 2005; 36 (6) 366-372
• 11 Rossi A, Cerone R, Biancheri R , et al. Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. AJNR Am J Neuroradiol 2001; 22 (3) 554-563
• 12 Thauvin-Robinet C, Roze E, Couvreur G , et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 2008; 79 (6) 725-728
• 13 Boxer AL, Kramer JH, Johnston K, Goldman J, Finley R, Miller BL. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology 2005; 64 (8) 1431-1434
• 14 Erbe RW, Salis RJ. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide—a cautionary tale. N Engl J Med 2003; 349 (1) 5-6
• 15 Lerner-Ellis JP, Anastasio N, Liu J , et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat 2009; 30 (7) 1072-1081
• 16 Gravel RA, Mahoney MJ, Ruddle FH, Rosenberg LE. Genetic complementation in heterokaryons of human fibroblasts defective in cobalamin metabolism. Proc Natl Acad Sci U S A 1975; 72 (8) 3181-3185
• 17 Froese DS, Zhang J, Healy S, Gravel RA. Mechanism of vitamin B12-responsiveness in cblC methylmalonic aciduria with homocystinuria. Mol Genet Metab 2009; 98 (4) 338-343
• 18 Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP. Hydroxocobalamin dose escalation improves metabolic control in cblC. J Inherit Metab Dis 2009; 32 (6) 728-731
• 19 Smulders YM, Smith DE, Kok RM , et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Hematol 2006; 132 (5) 623-629
• 20 Goodman SI, Moe PG, Hammond KB, Mudd SH, Uhlendorf BW. Homocystinuria with methylmalonic aciduria: two cases in a sibship. Biochem Med 1970; 4 (5) 500-515
• 21 Suormala T, Baumgartner MR, Coelho D , et al. The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. J Biol Chem 2004; 279 (41) 42742-42749
• 22 Coelho D, Suormala T, Stucki M , et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med 2008; 358 (14) 1454-1464
• 23 Rutsch F, Gailus S, Miousse IR , et al. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet 2009; 41 (2) 234-239
• 24 Zavadáková P, Fowler B, Suormala T , et al. cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat 2005; 25 (3) 239-247
• 25 Vilaseca MA, Vilarinho L, Zavadakova P , et al. CblE type of homocystinuria: mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene. J Inherit Metab Dis 2003; 26 (4) 361-369
• 26 Watkins D, Rosenblatt DS. Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity. Am J Med Genet 1989; 34 (3) 427-434
• 27 Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43 (4) 414-421
• 28 Engelbrecht V, Rassek M, Huismann J, Wendel U. MR and proton MR spectroscopy of the brain in hyperhomocysteinemia caused by methylenetetrahydrofolate reductase deficiency. AJNR Am J Neuroradiol 1997; 18 (3) 536-539
• 29 Tallur KK, Johnson DA, Kirk JM, Sandercock PA, Minns RA. Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene-tetrahydrofolate reductase deficiency: variable response in siblings. Dev Med Child Neurol 2005; 47 (1) 53-56
• 30 Arai M, Osaka H. Acute leukoencephalopathy possibly induced by phenytoin intoxication in an adult patient with methylenetetrahydrofolate reductase deficiency. Epilepsia 2011; 52 (7) e58-e61
• 31 Strauss KA, Morton DH, Puffenberger EG , et al. Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 2007; 91 (2) 165-175
• 32 Sofer Y, Harel L, Sharkia M, Amir J, Schoenfeld T, Straussberg R. Neurological manifestations of folate transport defect: case report and review of the literature. J Child Neurol 2007; 22 (6) 783-786
• 33 Hyland K, Shoffner J, Heales SJ. Cerebral folate deficiency. J Inherit Metab Dis 2010; 33 (5) 563-570
• 34 Pérez-Dueñas B, Toma C, Ormazábal A , et al. Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 2010; 33 (6) 795-802
• 35 Pineda M, Ormazabal A, López-Gallardo E , et al. Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion. Ann Neurol 2006; 59 (2) 394-398
• 36 Surtees R, Hyland K. Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionine declines with age in humans. Biochem Med Metab Biol 1990; 44 (2) 192-199
• 37 Banka S, Blom HJ, Walter J , et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet 2011; 88 (2) 216-225
• 38 Turgeon CT, Magera MJ, Cuthbert CD , et al. Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry. Clin Chem 2010; 56 (11) 1686-1695
• 39 Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 2006; 88 (4) 315-321
• 40 Tortorelli S, Turgeon CT, Lim JS , et al. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. J Pediatr 2010; 157 (2) 271-275